Abstract

ObjectivesTo define criteria based on the OMERACT rheumatoid arthritis MRI score (RAMRIS) which correspond to the 1-year EULAR response in a cohort of patients with rheumatoid arthritis.Methods94 patients (62 female...

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Similar Papers

Paper Title
Journal
Date
Author
THU0533 A SINGLE MRI DIXON SEQUENCE TO ASSESS DISEASE ACTIVITY AND CARTILAGE IN EARLY RHEUMATOID HANDS: ONE SEQUENCE TO ASSESS THEM ALL?
T Kirchgesner ... P Durez
-
T Kirchgesner, et. al.T Kirchgesner ... P Durez
01 Jun 2020
SAT0111 RED CELL DISTRIBUTION WIDTH IS A MARKER OF EARLY RESPONSE TO METHOTREXATE IN RHEUMATOID ARTHRITIS
Daniele Soddu ... Mattia Bellan
-
Daniele Soddu, et. al.Daniele Soddu ... Mattia Bellan
01 Jun 2019
Association between red cell distribution width and response to methotrexate in rheumatoid arthritis.
M Bellan ... M Pirisi
Reumatismo | VOL. 72
M Bellan, et. al.M Bellan ... M Pirisi
10 Apr 2020
The value of the simplified RAMRIS-5 in early RA patients under methotrexate therapy using high-field MRI
Miriam Frenken ... Benedikt Ostendorf
Arthritis Research & Therapy | VOL. 21
Miriam Frenken, et. al.Miriam Frenken ... Benedikt Ostendorf
14 Jan 2019
View more papers

More From: Annals of the Rheumatic Diseases

Paper Title
Journal
Date
Author
Expert consensus recommendations for the diagnosis and treatment of chronic non-bacterial osteitis (CNO) in adults
Elizabeth M Winter ... Anne T Leerling
Annals of the Rheumatic Diseases | VOL. -
Elizabeth M Winter, et. al.Elizabeth M Winter ... Anne T Leerling
28 Nov 2024
Ivarmacitinib, a selective Janus kinase 1 inhibitor, in patients with moderate-to-severe active rheumatoid arthritis and inadequate response to conventional synthetic DMARDs: results from a phase III randomised clinical trial
Jinjing Liu ... Xiaofeng Zeng
Annals of the Rheumatic Diseases | VOL. -
Jinjing Liu, et. al.Jinjing Liu ... Xiaofeng Zeng
27 Nov 2024
CD-19 CAR-T cells for polyrefractory rheumatoid arthritis
Merav Lidar ... Abraham Avigdor
Annals of the Rheumatic Diseases | VOL. -
Merav Lidar, et. al.Merav Lidar ... Abraham Avigdor
27 Nov 2024
Correction: Olokizumab plus methotrexate: safety and efficacy over 106 weeks of treatment
-
Annals of the Rheumatic Diseases | VOL. -
--
27 Nov 2024
View more papers

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.